Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine for Postoperative Mood and Pain in Crohn's Disease
NCT05506787Phase 4Completed
- Sponsor
- Jinling Hospital
- Start
- Sep 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and postoperative pain comparing Esketamine Group with Placebo Group (2 arms). Primary endpoint: Hamilton Depression Rating Scale-17. Started Sep 2020; status: completed.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)postoperative pain
Beyond the preview
Go deeper on NCT05506787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05506787.